Show Summary Details
Page of

Late-Life Depression: Evidence-Based Treatment 

Late-Life Depression: Evidence-Based Treatment
Chapter:
Late-Life Depression: Evidence-Based Treatment
Author(s):

Mark D. Miller

, Charles F. Reynolds

, Ariel Gildengers

, Ellen M. Whyte

, and Carmen Andreescu

DOI:
10.1093/med/9780199765782.003.0009
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 November 2020

Chapter 9 discusses how late-life depression increases the disability associated with medical comorbidity, worsens the perception of pain intensity, increases caregiver burden and is the greater risk factor for suicide, and reviews the evidence base for effective somatic treatments for late life depression, with emphasis on managing the high recurrence rates, as well as the subtypes of depression, including treatment resistant depression (TRD), vascular depression, Bipolar disorder, depression with psychosis, and depression comorbid with cognitive impairment.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.